BIONET Therapeutics Corp. (TPEX:7808)
Taiwan · Delayed Price · Currency is TWD 37.00
-0.15 (-0.40%)
At close: Oct 8, 2026
BIONET Therapeutics Market Cap
BIONET Therapeutics has a market cap or net worth of 2.59 billion as of October 9, 2026. It is the 26,886th most valuable company in the world and the 1,505th biggest in Taiwan. Its market cap has decreased by 39.74% in one year.
Market Cap
2.59B
Enterprise Value
1.58B
Revenue
196.63M
Global Rank
Country Rank
#1,505 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since December 12, 2024, BIONET Therapeutics's market cap has decreased from 3.82B to 2.59B, a decrease of -32.11%. That is a compound annual growth rate of -19.15%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 2.59B | -34.16% |
| Dec 31, 2025 | 3.93B | 20.99% |
| Dec 31, 2024 | 3.25B | -14.77% |
| Dec 12, 2024 | 3.82B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| HanchorBio | 23.66B |
| Elixiron Immunotherapeutics (Cayman) Limited | 20.28B |
| Obigen Pharma | 8.36B |
| Intelligene | 8.12B |
| Uwell Biopharma | 5.60B |
| Tripartite Therapeutics | 5.02B |
| Pet Pharm Biotech | 2.32B |
| Genomics BioSci & Tech. | 1.30B |